ประเด็น : ประชากร / เกิด / ตาย
เครื่องมือ : สถิติสุขภาพ
| ||||||||
Cause-specific mortality and morbidity
Cause-specific mortality rate (per 100 000 population) ---> HIV/AIDS Cause-specific mortality rate (per 100 000 population) ---> Malaria Cause-specific mortality rate (per 100 000 population) ---> TB among HIV-negative people Cause-specific mortality rate (per 100 000 population) ---> TB among HIV-positive people Distribution of years of life lost by broader causes(%)
(per 100000 population) ---> Communicable Distribution of causes of death among children aged
<5 years (%) ---> HIV/AIDS Distribution of causes of death among children aged
<5 years (%) ---> Diarrhoea Distribution of causes of death among children aged
<5 years (%) ---> Measles Distribution of causes of death among children aged
<5 years (%) ---> Malaria Distribution of causes of death among children aged
<5 years (%) ---> Pneumonia Distribution of causes of death among children aged
<5 years (%) ---> Neonatal sepsis Morbidity ---> MDG 6 Prevalence of tuberculosis(per 100 000
population) Morbidity ---> Incidence of tuberculosisj (per 100 000 population per year) Morbidity ---> MDG 6 Prevalence of HIV among adults aged >=15
years b (per 100 000 population) Selected infectious diseases Number of reported cases ---> Cholera Number of reported cases ---> Diphtheria Number of reported cases ---> H5N1 influenza Number of reported cases ---> Japanese encephalitis Number of reported cases ---> Leprosy Number of reported cases ---> Malaria Number of reported cases ---> Measles Number of reported cases ---> Meningitis Number of reported cases ---> Mumps Number of reported cases ---> Pertussis Number of reported cases ---> Plague Number of reported cases ---> Plague Number of reported cases ---> Poliomyelitis Number of reported cases ---> Congenital rubella syndrome Number of reported cases ---> Neonatal tetanus Number of reported cases ---> Total tetanus Number of reported cases --->Tuberculosis Number of reported cases ---> Yellow fever Health service coverage Neonates protected at birth against neonatal tetanus Immunization coverage among 1-year-olds ---> MDG 4 Measles Immunization coverage among 1-year-olds ---> DTP3 Immunization coverage among 1-year-olds ---> HepB3 Immunization coverage among 1-year-olds ---> Hib3 Children aged <5 years ---> MDG 6 Sleeping under insecticide-treated nets Children aged <5 years ---> MDG 6 With fever who received treatment with any antimalarial Children aged <5 years ---> With ARI symptoms taken to facility Children aged <5 years ---> With diarrhoea receiving ORT Antiretroviral therapy coverage ---> Pregnant women Antiretroviral therapy coverage ---> MDG 6 People with advanced HIV infection Antiretroviral therapy coverage ---> MDG 6 Smear-positive tuberculosis case-detection rate Antiretroviral therapy coverage ---> MDG 6 Smear-positive tuberculosis treatment-success rate Antiretroviral therapy coverage ---> MDG 6 Tuberculosis detection rate under DOTS Antiretroviral therapy coverage ---> MDG 6 Tuberculosis treatment success under DOTS Risk factors MDG 6 Prevalence of condom use by adults (15–49 years)
at higher-risk sex (%) ---> Male MDG 6 Prevalence of condom use by adults (15–49 years)
at higher-risk sex (%) ---> Female MDG 6 Prevalence of condom use by adults aged 15–49
years at last high-risk sex ---> Male MDG 6 Prevalence of condom use by adults aged 15–49
years at last high-risk sex ---> Female DG 6 Population aged 15–24 years with comprehensive
correct knowledge of HIV/AIDS ---> Male DG 6 Population aged 15–24 years with comprehensive
correct knowledge of HIV/AIDS ---> Female Condom use by young people (15-24 years) at higher
risk sexi ---> Male Condom use by young people (15-24 years) at higher
risk sexi ---> Female